Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

about

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

Item

http://www.wikidata.org/entity/Q58697579

description

scientific article published on 28 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

@en

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

@nl

type

Item

label

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

@en

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

@nl

prefLabel

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

@en

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

@nl

P1476

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

@en

P2093

David Bellocq

http://www.w3.org/2001/XMLSchema#string

Thibaud Mathis

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

Ranibizumab for neovascular age-related macular degeneration

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.

Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy.

Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

P304

8289253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1155/2018/8289253

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Kodjikian

P5008

ScienceSource

P577

2018-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30246026

http://www.w3.org/2001/XMLSchema#string

P921

macular retinal edema

dexamethasone

glucocorticoid

drug implants

P932

6136521

http://www.w3.org/2001/XMLSchema#string